| [1] |
Davin JC, Rutjes NW. Nephrotic syndrome in children: from bench to treatment [J]．Int J Nephrol, 2011, 10(8): 1-6.
|
| [2] |
周琼秀，陈楠. 成人激素抵抗性肾病综合征遗传学机制[J]. 肾脏病与透析肾移植杂志，2013，22(1)：70-74.
|
| [3] |
陈春梅，夏运成. 原发性肾病综合征激素抵抗的研究现状[J]．广东医学，2014, 35(3): 461-464.
|
| [4] |
王雪，耿龙，季永智，等. 糖皮质激素对其受体、热休克蛋白90和组蛋白去乙酰化酶6的影响及中药干预研究[J]. 中国医科大学学报，2010，39(8)：607-609.
|
| [5] |
Stachowskl J, Zanker CB, Runowski D, et al.Resistance to therapy in primary nephrotic syndrome: effect of MDR1 gene activity [J]．POL Merkuriusz Lek, 2000, 8(46): 218-221.
|
| [6] |
李世军，刘志红. 改善全球肾脏病预后组织(KDIGO)临床实践指南：肾小球肾炎[J]．肾脏病与透析肾移植杂志，2012，21(3)：260-267.
|
| [7] |
Kamburova EG, Koenen HJ, Borgman KJ，et al.A single dose of rituximab does not deplete B ceils in secondary lymphoid organs but alters phenotype and function [J]．Am J Transplant，2013，13(6)：1503-1511.
|
| [8] |
Audard V, Lang P, Sahali D. Minimal change nephrotic syndrome：new insights into disease pathogenesis [J]．Med Sci (Paris)，2008，24(10)：853-858.
|
| [9] |
Sinha A, Bagga A. Rituximab therapy in nephrotic syndrome: implications for patients′ management [J]. Nat Rev Nephrol, 2013, 9(3): 154-169.
|
| [10] |
Ito S, Kamei K, Ogura M，et al. Survey of rituximab treatment for childhood-onset refractory nephritic syndrome [J]. Pediatr Nephrol, 2013, 28(2): 257-264.
|
| [11] |
Gulati A, Sinha A, Jordan SC，et al. Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report [J]. Clin J Am Soc Nephrol, 2010, 5(12): 2207-2212.
|
| [12] |
Prytula A, Iijima K, Kamei K, et al. Rituximab in refractory nephrotic syndrome [J]. Pediatr Nephrol, 2010, 25(3): 461-468.
|
| [13] |
Fernandez-Fresnedo G, Segarra A, González E，et al. Rituximab treatment of adult patients with steroid -resistant focal segmental glomerulosclerosis [J]. Clin J Am Soc Nephrol, 2009, 4(8): 1317-1323.
|
| [14] |
Bomback AS, Derebail VK, McGregor JG, et al. Rituximab therapy for membranous nephropathy: a systematic review [J]. Clin J Am Soc Nephrol, 2009, 4(4): 734-744.
|
| [15] |
Cravedi P, Sghirlanzoni MC, Marasà M, et al. Efficacy and safety of rituximab second-line therapy for membranous nephropathy: a prospective, matched-cohort study [J]. Am J Nephrol, 2011, 33(5): 461-468.
|
| [16] |
Saran AM, Yuan H, Takeuchi E，et al.Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy [J]．Kidney Int，2003，64(6)：2072-2078.
|
| [17] |
Miwa T, Zhou L, Maldonado MA，et al.Absence of CD59 exacerbates systemic autoimmunity in MRL/lpr mice [J]．J Immunol，2012, 189(11)：5434-5441.
|
| [18] |
Saleem MA. New developments in steroid-resistant nephrotic syndrome [J]. Pediatr Nephrol, 2013, 28(5): 699-709.
|
| [19] |
Hogan J, Mohan P, Appel GB. Diagnostic tests and treatment options in glomerular disease: 2014 update [J]. Am J Kidney Dis, 2014, 63(4): 656-666.
|
| [20] |
陈朝红，刘志红，孙骅，等．雷公藤甲素干预足细胞病变的体外观察[J]，肾脏病移植与透析杂志，2007，16(2)：119-126.
|
| [21] |
叶任高，孙升云．难治性肾病综合征探析[J]．新中医，2002，34(6)：3-5.
|